Delivery Order SPE2DB24D9222-SPE2DB25FAZHT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) with an ultimate completion date of September 26, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its primary location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count units. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Nuplazid 34 mg capsules and has a performance period through May 12, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units) with a ceiling value of $3,458.51. The contract was awarded on September 9, 2025, with an ultimate completion date of September 30, 2025, utilizing firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $3,458.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 16, 2025, for the supply of Nuplazid 34 mg capsules (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30. This firm fixed-price delivery order, which carries an ultimate completion date of September 3, 2025, represents a direct procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois, and supports the pharmaceutical supply needs of Department...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,375.53 firm fixed-price contract is for the delivery of Nuplazid 34 mg capsules, with a completion date of July 7, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,375.53 by the Defense Logistics Agency on July 18, 2025, for the supply of Nuplazid 34 mg capsules (30-count units). This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge, Illinois location. The award represents a...
- The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS...
- SPE2DB24D9222Indefinite Delivery Contract
- SPE2DB24D9222-SPE2DB25FAZHTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units). This firm fixed-price delivery order, issued on June 4, 2025, with an ultimate completion date of June 26, 2025, represents a specific pharmaceutical product draw-down from DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis. Performance will take place at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, holds a significant master contract vehicle with DLA valued at $499,999,999 and valid through November 2026. This master contract enables the agency to issue delivery orders for an extensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems, positioning itself as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 6/4/25 |